BIOLIT ApS: Financial statements 2015
CVR: 10068460
Source: annual report 2015, Danish Business Authority
01/06/2014 – 31/05/2015
BIOLIT ApS (CVR 10068460) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 1,085,761 and a net result of DKK 795,143 compared with DKK 616,651 the year before. That is an increase of 45.5% compared with the year before. Equity in the 2015 report amounted to DKK 2,247,637. The solvency ratio was 44.6%.
- Gross Profit
- DKK 1,085,761
- Profit/Loss
- DKK 795,143
- Equity
- DKK 2,247,637
- Total Assets
- DKK 5,035,016
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 1.1 mio. | 795 t. | 2.2 mio. | - |
| 2014 | - | 746 t. | 617 t. | 1.5 mio. | - |
| 2013 | - | 911 t. | 602 t. | 836 t. | - |
How creditworthy is BIOLIT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BIOLIT ApS
BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees (2006). In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity in the 2025 report amounted to DKK 10,762,624.